Evidence map›Paper›PMID 42743272›Full record

ArticlePloS one2026

Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer.

Alonso Espinoza, Eric Goles, Marco Montalva-Medel

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alonso EspinozaFacultad de Ingenieria y Ciencias, Univesidad Adolfo Ibañez, Santiago, Chile.ORCID https://orcid.org/0009-0009-4643-5003
Eric GolesFacultad de Ingenieria y Ciencias, Univesidad Adolfo Ibañez, Santiago, Chile.
Marco Montalva-MedelFacultad de Ingenieria y Ciencias, Univesidad Adolfo Ibañez, Santiago, Chile.ORCID https://orcid.org/0000-0002-7264-9840

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boolean networks are powerful frameworks for capturing the logic of gene-regulatory circuits, yet their combinatorial explosion hampers exhaustive analyses. Here, we present a systematic reduction of a published 31-node Boolean model that describes cisplatin- and pemetrexed-resistance in non-small-cell lung cancer to a compact 9-node core that exactly reproduces the original attractor landscape. Through a sequence of biologically guided reductions (31→29→14→9 nodes), the streamlined network shrinks the state space by four orders of magnitude, enabling rapid exploration of critical control points, rules fitting, and candidate therapeutic targets. Extensive synchronous and asynchronous simulations, combined with a Boolean rule-fitting algorithm that removes spurious limit cycles, confirm that the three clinically relevant steady states and their basins of attraction are conserved and reflect resistance frequencies close to those reported in clinical studies. The reduced model provides an accessible scaffold for future mechanistic and drug-discovery studies.

Indexed as

Carcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmGene Regulatory NetworksLung NeoplasmsAlgorithmsAntineoplastic AgentsCisplatinGlutamatesGuanineHumansPemetrexedAntineoplastic AgentsCisplatinGlutamatesGuaninePemetrexed

Identifiers

PMID42743272
PMCPMC13577482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.